LivaNova PLC

US$89.99As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LIVNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 4.72%
Div yield —
ROE 15.50%
Medical Devices
Beta (5Y) 0.92
PE TTM 25.73
TSR TTM 70.99%
Mkt cap US$4.957B
ROIC 18.52%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$115
28.02%
(73.79%)
Hold 6|9|4|5|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
1.95
2.09
2.11
2.26
30.77%
39.57%
25.97%
21.39%
Revenue$M
356.8
355.3
369.4
390.8
(0.44%)
(1.04%)
2.90%
10.51%
Peers (US$4.957B)
Cap (US$)
PE
13.08B
20.86x
6.585B
53.61x
362.4M
39.25x
Capital
TTM
5Y
10Y
Leveragex
0.748
(0.265)
(0.250)
EBIT/Intx
0.651
0.130
0.135
Own earn%
(71.76)
330.79
303.85
Sh yield%
18.29
48.34
48.30
Owners
Insiders/Inst%
11.24
52.78
Short interest%
4.52
SBC / revenue%
0.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
21–25
$1 testx
—
Incr. ROIC%
4